Neurophet
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth 2024-11-15 22:00
Neurophet partners with Beijing LADO Technology… Intends to establish Joint Venture in China 2024-10-30 21:00
Neurophet to host Symposium featuring renowned expert in Alzheimer's disease treatment from the U.S. 2024-10-18 21:00
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' 2024-10-15 21:00
Neurophet-NTU Singapore, recognized for outstanding joint research 2024-09-09 21:00
Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024 2024-07-25 21:00
Neurophet to present brain stimulation simulation study at OHBM 2024 2024-06-26 21:00
Neurophet to participate BIO USA… exploring global partnership and business 2024-05-31 21:00
Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024 2024-03-04 22:00
Neurophet to showcase brain image analysis technology at RSNA 2023 2023-11-23 22:00
Neurophet, the first company in Korea, selected by Roche Diagnostics for Startup Creasphere's APAC innovation program 2023-09-05 21:00
Neurophet to unveil brain image analysis technology related to treatment of Alzheimer's disease at AAIC 2023 2023-07-18 21:00
Neurophet receives FDA 510(k) Clearance for Neurophet AQUA 2023-05-18 21:00
Neurophet to unveil new technology for analyzing ARIA side effect at ECR 2023 2023-03-02 22:00
Neurophet, to participate in the Radiological Society of North America RSNA 2022 2022-11-25 22:00
1